Clinical trials of IMAB027 (NCT02054351) and ASP1650 (NCT03760081) (http://clinicaltrials.gov) developed with Claudin-6 as the target have been carried out in ovarian cancer, germinoma and other malignant tumors25. Here, CLDN6 is linked to ovarian carcinoma.